33 34 Background: Osteoarthritis (OA) is the most common form of arthritis and characterized by 35 degeneration of articular cartilage. Mitogen-inducible gene 6 (Mig-6) has been identified as a 36 negative regulator of the Epidermal Growth Factor Receptor (EGFR). Cartilage-specific Mig-6 37 knockout (KO) mice display increased EGFR signaling, an anabolic buildup of articular cartilage 38 and formation of chondro-osseous nodules. Since our understanding of the EGFR/Mig-6 network 39 in cartilage remains incomplete, we characterized mice with cartilage-specific overexpression of 40 Mig-6 in this study. 41 Methods: Utilizing knee joints from cartilage-specific Mig-6 overexpressing (Mig-6over/over ) mice 42 (at multiple time points), we evaluated the articular cartilage using histology, 43 immunohistochemical staining and semi-quantitative OARSI scoring at multiple ages. MicroCT 44 analysis was employed to examine skeletal morphometry, body composition, and bone mineral 45 density. 46 Results: Our data show that cartilage-specific Mig-6 overexpression did not cause any major 47 developmental abnormalities in articular cartilage, although Mig-6 over/over mice have slightly 48 shorter long bones compared to the control group. Moreover, there was no significant difference 49 in bone mineral density and body composition in any of the groups. However, our results indicate 50 that Mig-6 over/over male mice show accelerated cartilage degeneration at 12 and 18 months of age. 51 Immunohistochemistry for SOX9 demonstrated that the number of positively stained cells in Mig-52 6 over/over mice decreased relative to controls. Immunostaining for MMP13 staining is increased in 53 areas of cartilage degeneration in Mig-6 over/over mice. Moreover, staining for phospho-EGFR (Tyr-54 1173) and lubricin (PRG4) was decreased in the articular cartilage of Mig-6 over/over mice. 55 Conclusion: Overexpression of Mig-6 in articular cartilage causes no major developmental 56 phenotype; however these mice develop earlier OA during aging. These data demonstrate that 57
The authors have no conflicts of interest to declare. 31 INTRODUCTION signaling and activates various cell-signaling pathways in chondrocytes, including extracellular 96 signal-regulated kinase 1 and 2 (ERK1/2) and P13K (phosphoinositide 3-kinase) (29). EGFR 97 signaling plays important roles in endochondral ossification (30,31), growth plate development 98 (30) and cartilage maintenance and homeostasis (32-34), but many aspects of its action in cartilage 99 are still not well understood. However, both protective and catabolic effects of EGFR signaling in 100 OA have been reported, suggesting context-specific roles of this pathway (35) . 101
Mitogen-inducible gene 6 (Mig-6) is also known as Gene 33, ErbB receptor feedback 102 inhibitor 1 (ERRFI1), or RALT, and is found in the cytosol (36). Mig-6 protein binds to and inhibits 103 EGFR signaling through a two-tiered mechanism: suppression of EGFR catalytic activity and 104 receptor down-regulation (37). Interestingly, various studies have reported that loss of Mig-6 105 induces the onset of OA-like symptoms in mice (36, (38) (39) (40) . Cartilage-specific (Col2-Cre) 106 knockout of Mig-6 mice results in formation of chondro-osseous nodules in the knee, but also 107 increased thickness of articular cartilage in the knee, ankle, and elbow (41). Prx1-cre-mediated 108 knockout of Mig-6 results in a similar phenotype as that observed in cartilage-specific knockout 109 mice(42). These phenotypes appeared to be caused by an increase in chondrocyte proliferation in 110 articular cartilage, supported by increased expression of Sox9 and EGFR activation in cartilage 111 (42) . Since our studies suggest dosage-and/or context-specific roles of EGFR signaling in the 112 process of cartilage degeneration in OA, in this study we used a Col2a1 promoter-driven Cre/lox 113 system to examine effects of Mig-6 overexpression specifically in articular cartilage. 114 115
Materials and Methods 116

Generation of Mig-6 overexpression mice 117
Mig-6 overexpression animals on a mixed C57Bl/6 and agouti mouse background, with the 118 overexpression cassette in the Rosa26 locus (43) and bred for 10 generations into a C57Bl/6 119 background. Transcription of Mig-6 is under the control of a ubiquitously expressed chicken beta 120 actin-cytomegalovirus hybrid (CAGGS) promoter, but blocked by a "Stop Cassette" flanked by 121
LoxP sites (LSL) (43). Mig-6 overexpression mice were bred to mice carrying the Cre recombinase 122 gene under the control of the Collagen 2 promoter (44), to induce recombination and removal of 123 the Stop Cassette specifically in cartilage. Throughout the manuscript, animals for homozygote 124 overexpression of Mig-6 from both alleles are termed Mig-6 over/over over/over Col2a1-Cre +/-), 125 while control mice are identical but without the Cre gene (noted as "control" in this manuscript for 126 simplicity). Mice were group housed (at least 1 pair of littermate matched control and overexpression animals), on a standard 12 hour light/dark cycle, without access to running wheels, 128 and with free access to mouse chow and water. Animals were weighed prior to euthanization by 129 asphyxiation with CO2. All EDTA in phosphate buffered saline (PBS), pH 7.0. Joints were processed and embedded in 144 paraffin in sagittal or frontal orientation, with serial sections taken at a thickness of 5 μm. Sections 145 were stained with Toluidine Blue (0.04% toluidine blue in 0.2M acetate buffer, pH 4.0, for 10 146 minutes) for glycosaminoglycan content and general evaluation of articular cartilage. All images 147 were taken with a Leica DFC295 digital camera and a Leica DM1000 microscope. 148
Thickness of proximal tibia growth plate 149
For early developmental time points such as newborn (P0), sagittal knee sections stained 150 with toluidine blue were used to measure the width of the zones of the epiphyseal growth plate in 151 the proximal tibia. The average thickness of the resting and proliferative zones combined was 152 evaluated by taking three separate measurements at approximately equal intervals across the width 153 of the growth plate. The average hypertrophic zone thickness was also measured using 3 different 154 measurements across the width of the growth plate, starting each measurement at the border of the 155 proliferative and hypertrophic zones and ending at the subchondral bone interface. A third average 156 measurement was then taken of the thickness of the entire growth plate. ImageJ Software (v.1.51) 157 (45) was used for all measures, with the observer blinded to the genotype.
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Articular cartilage evaluation 159
Articular cartilage thickness was measured from toluidine blue-stained frontal sections by 160 a blinded observer. Articular cartilage thickness was measured separately for the non-calcified 161 articular cartilage (measured from the superficial tangential zone to the tidemark) and the calcified 162 articular cartilage (measured from the subchondral bone to the tidemark) across three evenly 163 spaced points from all four quadrant of the joint (medial/lateral tibia and femur) in 4 sections 164 spanning at least 500 μm. ImageJ Software (v.1.51) (45) was used to measure the thickness of 165 articular cartilage. 166
Micro-Computerized Tomography (μCT) 167
Whole body scans were collected in 6 week-, 11 week-, 12 month-and 18 month-old 168 control and Mig-6 over/over male and female mice. Mice were euthanized and imaged using General 169 Electric (GE) SpeCZT microCT machine (46) at a resolution of 50μm/voxel or 100μm/voxel. GE 170
Healthcare MicroView software (v2.2) was used to generate 2D maximum intensity projection and 171 3D isosurface images to evaluate skeletal morphology. MicroView was used to create a line 172 measurement tool in order to calculate the bone lengths, femurs lengths were calculated from the 173 proximal point of the greater trochanter to the base of the lateral femoral condyle. Tibiae lengths 174
were measured from the midpoint medial plateau to the medial malleolus. Humerus lengths were 175 measured from the midpoint of the greater tubercle to the center of the olecranon fossa. 176
Body Composition Analysis 178
MicroView software (GE Healthcare Biosciences) was used to analyse the microCT scans 179 at the resolution of 100um/voxel. Briefly, the region of interest (ROI) was used to calculate the 180 mean of air, water and an epoxy-based, cortical bone-mimicking calibrator (SB3; Gammex, 181 Middleton, WI, USA) (1100mg/cm 3 ) (47). A different set of global thresholds was applied to 182 measure adipose, lean and skeletal mass (− 275, − 40 and 280 Hounsfield Units (HU), 183 respectively). Moreover, bone mineral density (BMD) was acquired as the ratio of the average HU 184 (from the value of skeletal region of interest ) in order to calculate HU value of the SB3 calibrator, 185 multiplied by the known density of the SB3 as described (46). 186
187
OARSI histopathology scoring 188
Serial sections through the entire knee joint were scored according to the OARSI histopathology scoring system (48) by two blinded observers on the four quadrants of the knee: 190 lateral femoral condyle (LFC), lateral tibial plateau (LTP), medial femoral condyle (MFC), and 191 medial tibial plateau (MTP). Histologic scoring from 0-6 represent the OA severity, from 0 192 (healthy cartilage) to 6 (erosion of more than 75% of articular cartilage). Individual scores are 193 averaged across observers and OA severity is shown as described for each graph. Scores were 194 compared between male and female Mig-6 over/over and control mice at both 12 and 18 months of 195 age. All images were taken with a Leica DFC295 digital camera and a Leica DM1000 microscope. 196
Immunohistochemistry 197
Frontal paraffin sections of knees were used to for immunohistochemical analysis, with 198 slides with 'no primary antibody' as control. All sections were deparaffinized and rehydrated as 199 previously described (41,49). Subsequently, the sections were incubated in 3% H2O2 in methanol 200 for 15 minutes to inhibit endogenous peroxidase activity. After rising with water, 5% goat or 201 donkey serum in PBS was applied to reduce nonspecific background staining. Overexpressing mice were obtained at the expected Mendelian ratios (data not shown). Male 228 mutant gained weight at the same rate as controls over the examined at 10 week period, while 229 female Mig-6 over/over mice were slightly lighter than controls starting at 8 weeks of age ( Fig. 1A,B ). 230
These differences persisted at 12 months of age for female mice, while at 18 months both male 231 and female mutant mice were lighter than their controls (Fig. 1C,D) . 232
Growth plates of post-natal day 0 (P0) Mig-6 over/over and control mice were analyzed by 233 histology. No major differences in tibia growth plate architecture were seen between genotypes 234 ( Fig. 2A ). While the length of the total growth plate was slightly reduced in Mig-6 over/over mice, 235 differences in lengths of either the combined resting/proliferative or hypertrophic zones were not 236 statistically significant ( Fig. 2B-D) . 237 238
Mice overexpressing Mig-6 have shorter long bones than control mice 239
Skeletal morphology and bone length were examined by microCT mice at the ages of 6 240 and weeks, and 12 and 18 months. Scans of Mig-6 over/over male and female mice and their controls 241 were used to generate 3D isosurface reconstructions of 100μm/voxel uCT scans, in order to 242 measure long bones lengths (femurs, humeri, and tibiae) in GE MicroView v2.2 software. Mutant 243 bones were slightly shorter throughout life, with the exception of the male humeri at 12 months 244 that did not show any statistically significant difference (Fig. 3) . In contrast, male mice did not 245 show any differences in bone mineral density at 11 weeks, 12 months, or 18 months, compared to 246 controls (Suppl. Fig. 2 ). In addition, no differences in body mass composition were seen in male 247 mutant and control mice at 11 weeks, 12 months, and 18 months of age (Suppl. Fig. 3 ). 248 249
Mig-6 overexpressing mice have healthy articular cartilage during skeletal maturity 250
We next examined articular cartilage morphology in 11 week-old mutant and control mice 251 using toluidine blue stained paraffin frontal knee sections ( Fig. 4A-B Since aging is a primary risk factor in OA (50), we next examined knee joints in 12 and 18 month-262 old control and Mig-6 over/over mice. Toluidine blue stained sections were evaluated by two blinded 263 observers, using OARSI recommendations (48). At 12 month of age, male control mice showed 264 minor signs of cartilage damage, such as loss of proteoglycan staining, but no significant structural 265 degeneration ( Fig. 5A ). However, seven of nine Mig-6 over/over male mice showed more extensive 266 cartilage damage in their medial side (erosion to the calcified layer lesion for 25% to 50% of the 267 medial quadrant). OARSI scoring confirmed increased OA-like damage in mutant mice ( Fig. 5C ). 268
Similarly, at 18 months of age the male control group showed minimal cartilage degeneration in 3 269 of 6 mice ( Fig. 6A ). Mig-6 over/over male mice showed more severe cartilage erosion in the medial 270 tibial plateau in 4/6 animals. This result was again supported by significantly increased OARSI 271 cartilage damage scores ( Fig. 6C ). Moreover, for the female group at 12 months, control mice did 272 not show cartilage damage in any quadrant of the knee. Mig-6 over/over female mice showed sign of 273 OA-like cartilage damage in 3/8 animals ( Supplementary Fig. 5 ). In addition, at 18 months of age, 274 female control mice showed healthy cartilage, and 4/8 Mig-6 over/over female mice showed some 275 proteoglycan loss and cartilage degeneration on the medial side ( Supplementary Fig. 6 ). 276
Overexpression of Mig-6 decreases EGFR phosphorylation and Sox9 expression 277
Since Mig-6 negatively regulates EGFR signaling (32,33,41), immunohistochemistry was 278 performed for phospho-EGFR (Tyr-1173) (pEGFR), with no primary antibody controls. Frontal 279 knee sections from 11 weeks-old male Mig-6 over/over mice showed decreased pEGFR staining in 280 the medial compartment in the knee joint ( Fig.7) , as expected upon Mig-6 overexpression. 281
During chondrogenesis, the transcription factor SOX9 is required for cartilage formation 282 and normal expression of collagen and aggrecan (51). Sagittal and frontal sections of paraffin embedded knees from post-natal day 0 (P0), 6 weeks-old, 11 weeks-old, 12 months and 18 months 284 male mice were used for SOX9 immunostaining. At P0, nuclear SOX9 expression was observed 285 in the resting and proliferative zone of the growth plate in both genotypes ( Fig. 8A,B ). Cell density 286 was not different between genotypes (Fig. 8C ). In control mice, 78 % of chondrocytes were 287 positive for SOX 9 immunostaining, while the proportion of positive cells was only 53 % in Mig-288 6 over/over mice ( Fig 8D) . In 6 and 11-weeks-old mice, SOX9 was present in the articular cartilage 289 in all four quadrants ( Fig. 9A,B) . At 6 weeks-old the total cell number in control male and Mig-290 6 over/over mice is similar ( Fig. 9C ), but the percentage of SOX9 positive cells was decreased in 291 mutant mice ( Fig 9D) . A similar phenotype was present at 11 weeks ( Supplementary Fig 7) . At 12 292 months of age, SOX9 is present more in the lateral side (LTP and LFC) than the medial side (MTP 293 and MFC) in both strains, with a few positive cells present in the medial side of the control strain. 294
On the other hand, Mig-6 over/over mice showed fewer SOX9-positive cells on the medial side due 295 the articular cartilage damage (Fig 10) . Similar results were found at 18 month of age in Mig-6 296 over/over with decreased SOX9 immunostaining in their medial side compared to the control (data 297 not shown). For all ages, negative controls did not show staining in chondrocytes. 298 299
Overexpression of Mig-6 decreases expression of lubricin 300
Lubricin (aka PRG4/superficial zone protein) is a proteoglycan that plays an important role 301 as lubricant in the joint (52). EGFR signaling is crucial for the cartilage lubrication function and 302 regulates the induction of Prg4 expression which is necessary for smooth movement (33,53). 303
Immunohistochemistry for Lubricin in 11 week-old and 12 months-old animals demonstrated less 304 staining in the superficial zone of the medial side of Mig-6 over/over mice than in the control group 305 ( Fig.11 and Fig. 12) . Previous research demonstrates that Mig-6 overexpression acts as a negative feedback 333 regulator of EGFR-ERK signalling (43), however these studies did not yet analyze joint tissues. 334
Since our studies suggest dosage-and/or context-specific roles of EGFR signaling in joint 335 homeostasis and OA (35), we now examined whether overexpression of Mig-6 alters these 336 processes. Here, we report that cartilage-specific constitutive overexpression of Mig-6 did not 337 cause cartilage degeneration in young mice, but early onset OA in middle aged mice. While we 338 observed some effects of Mig-6 overexpression on bone length and weight, these effects were 339 subtle and not accompanied by major morphological or histological changes in growth plate 340 cartilage, overall skeletal morphology, or body composition. A previous study showed that 341 deletion of EGFR in bone tissue (Col1-Cre Egfr Wa5/f ) resulted in shorter femurs compared to wild-342 type mice (66), consistent with our findings. The EGFR network is essential during long bone 343 development, since previous studies have shown that EGFR-or TGF-deficient mice exhibit a 344 widened zone of hypertrophic chondrocytes (24,67). Moreover, Qin and colleagues have shown 345 that administration of the EGFR inhibitor, gefitinib, into 1-monht-old rats results in an enlarged 346 hypertrophic zone due down-regulation of MMP-9,-13 and -14 (31). Together these data suggest a critical role of EGFR during endochondral ossification and elucidate downstream mechanism of 348 EGFR (68). Further research is required to provide more evidence of EGFR/Mig-6 over/over 349 signalling during bone formation, but many of these effects are relatively subtle and transient, and 350 likely unrelated to much more severe phenotypes observed later. 351
Histologically, our findings showed that mice with cartilage-specific Mig-6 overexpressing 352 showed healthy articular cartilage with no significant difference in articular cartilage thickness 353 from control group at the ages of 6 weeks and 11 weeks. However, Mig-6 over/over mice developed 354 severe degeneration of articular cartilage with aging. More prevalent, the knee joints of Mig-6 355 over/over male mice showed significantly advanced cartilage degeneration. The same pattern but 356 with more severe damage, was seen in 18 month-old mice. As previously described, sex hormones 357 play a role in OA disease where male mice develop more severe OA (69). 358 SOX9 is crucial in chondrogenesis during endochondral bone formation, articular cartilage 359 development and cartilage homeostasis (51). Previous in vivo models using cartilage (Col2)-Cre 360 or limb (Prx1)-Cre specific ablation of Mig-6 showed increased expression of SOX9 in the 361 articular cartilage. Also, TGFα supresses expression of anabolic genes such as Sox9, type II 362 collagen and aggrecan in primary chondrocytes (71). Interestingly, in the medial and lateral 363 compartment of the knee joints of 6 and 11 week-old male Mig-6 over/over mice, the percentage 364 of SOX9-positive chondrocytes was decreased compared to controls, despite the absence of 365 histological defects in articular cartilage. These data suggest that reduced number of Sox9-366 expressing cells precede the degeneration of articular chondrocytes in our mutant mice. The 367 number of SOX9-expressing cells was also reduced in Mig-6 over/over mice at later ages. These data 368 suggest that reduced numbers of Sox9-expressing cells could be one cause of the advanced OA in 369 our mutant mice. In addition, we observed decreased expression of lubricin/PRG4 in these joints, 370 which might also contribute to the observed joint pathologies. PRG4 has been shown to be 371 regulated by EGFR signaling before (42,53), in support of our findings. 372
While the EGFR is the best characterized substrate of Mig-6, other substrates have been 373 described. Mig-6 binds to different proteins such as the cell division control protein 42 homolog 374 (Cdc42) (72), c-Abl (73), and the hepatocyte growth factor receptor c-Met (74). While we cannot 375 exclude that deregulation of these other substrates contributes to the observed phenotypes, the 376 similarities of defects in our mice with those seen upon cartilage-specific deletion of EGFR suggest 377 that decreased EGFR signaling is the main cause for the advanced OA observed in our mutant 378 mice. Nevertheless, it will be important to determine whether signaling through cMet and other pathways is altered as well. 380
In conclusion, we show for the first time that cartilage-specific Mig-6 overexpression in 381 mice results in reduced EGFR activity in chondrocytes, reduced SOX9 and PRG4 expression , and 382 accelerated development of OA. These data highlight the important and context-specific role of 383 the EGFR-Mig-6 signaling pathway in joint homeostasis and point towards potential targeting of 384 this pathway for OA therapy. Therefore, there was no significant differences within the groups. Individual data points presented with mean ± SEM analyzed by two tailed student t-tests; ( P<0.05). 
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